Psychological implications of ICD implantation in a New Zealand population

Europace

Volumn 9, Issue 1, 2007, Pages 20-24

  Newall, E G ^a   Lever, N A ^b   Prasad, S ^b   Hornabrook, C ^b   Larsen, Peter D ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Anxiety; Depression; Implantable cardioverter defibrillators; Pacemakers; Quality of life

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGE; AGED; ANXIETY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONTROLLED STUDY; DEFIBRILLATOR; DEPRESSION; FEMALE; FOLLOW UP; GENDER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PATIENT SATISFACTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SCORING SYSTEM; SUDDEN DEATH;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; DEFIBRILLATORS, IMPLANTABLE; DEPRESSION; FEMALE; HUMANS; INCIDENCE; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33846505364     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul142     Document Type: Article

References (23)

1. Mirowski M, Mower MM, Staewen WS, Tabatznik B, Mendeloff AI. Standby automatic defibrillator. An approach to prevention of sudden coronary death. Arch Intern Med 1970;126:158-61.
2. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5.
3. Dunbar SB. Psychosocial issues of patients with implantable cardioverter defibrillators. Am J Crit Care 2005;14:294-303.
4. Hauer RN, Aliot E, Block M, Capucci A, Lüderitz B, Santini M, Vardas PE. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Eur Heart J 2001;22:1074-81.
5. Hegel MT, Griegel LE, Black C, Gouiden L, Ozahowski T. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. Int J Psychiatry Med 1997;27:57-69.
6. Lewin RJ, Frizelle DJ, Kaye GC. A rehabilitative approach to patients with internal cardioverter-defibrillators. Heart 2001;85:371-2.
7. Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004;66:714-9.
8. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002;87:488-93.
9. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quatity of life in patients with implantable cardioverter defibrillators. Psychosomatics 2005;46:451-7.
10. Sears SF Jr, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review. Clin Cardiol 1999;22:481-9.
11. Duru F, Buchi S, Klaghofer R, Mattmann H, Sensky T, Buddeberg C, Candinas R. How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life? Heart 2001;85:375-9.
12. Carroll DL, Hamilton GA, Kenney BJ. Changes in health status, psychological distress, and quality of life in implantable cardioverter defibrillator recipients between 6 months and 1 year after implantation. Eur J Cardiovasc Nurs 2002;1:213-9.
13. May CD, Smith PR, Murdock CJ, Davis MJ. The impact of the implantable cardioverter defibrillator on quality-of-life. Pacing Clin Electrophysiol 1995;18:1411-8.
14. Burg MM, Lampert R, Joska T, Batsford W, Jain D. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med 2004;66:898-902.
15. Bambauer KZ, Locke SE, Aupont O, Mullan MG, McLaughlin TJ. Using the Hospital Anxiety and Depression Scale to screen for depression in cardiac patients. Gen Hosp Psychiatry 2005;27:275-84.
16. Ware JE KM, Keller SD. How to Score Version 2 of the SF-36(R). Lincoln, RI, USA: Quality Metric.
17. Pelletier D, Gallagher R, Mitten-Lewis S, McKinley S, Squire J. Australian implantable cardiac defibrillator recipients: Quatity-of-life issues. Int J Nurs Pract 2002;8:68-74.
18. Leosdottir M, Sigurdsson E, Reimarsdottir G, Gottskalksson G, Torfason B, Vigfusdottir M, Eggertsson S, Arnar DO. Health-related quatity of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. Europace 2006;8:168-74.
19. The nature and prevalence of psychological, problems in New Zealand primary healthcare: A report on Mental Health and General Practice Investigation (MaGPle). N Z Med J 2003;116:U379.
20. Williams AM, Young J, Nikoletti S, McRae S. Reasons for attending and not attending a support group for recipients of implantable cardoverter defibrillators and their carers. Int J Nurs Pract 2004;10:127-33.
21. Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: A randomised controlled trial. Heart 2003;89:155-60.
22. Watkins E, Brown RG. Rumination and executive function in depression: An experimental study. J Neurol Neurosurg Psychiatry 2002;72:400-2.
23. Nolen-Hoeksema S. The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. J Abnorm Psychol 2000;109:504-11.